Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 600
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00005626 | Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11) | ||
| NCT02157610 | Smoking Cessation for Cervical Cancer Survivors | ||
| NCT00496340 | Phase II Trial of Pentostatin and Targeted Busulfan | ||
| NCT02973750 | Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer | ||
| NCT00624585 | Study of Oral Dasatinib in Subjects With Myelodysplastic Syndrome (MDS) and Excess Marrow Blasts | ||
| NCT06088498 | App for Reducing Cravings to Smoke | ||
| NCT00231465 | Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer | ||
| NCT06050395 | The MONITOR Study: Remote Monitoring Of a Nutrition Intervention To Optimize Treatment Response | ||
| NCT01455311 | Evaluation of Image-guided Brushing of Pancreatic Cyst Wall in Diagnosis of Cystic Pancreatic Tumors | ||
| NCT05645471 | Together After Cancer | ||
| NCT04160065 | Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers | ||
| NCT05316116 | Siltuximab in Large Granular Lymphocytic Leukemia (LGLL) | ||
| NCT01859026 | A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR Mutation | ||
| NCT06378047 | Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer | ||
| NCT02186834 | Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple Myeloma | ||
| NCT01683149 | Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies | ||
| NCT00816985 | Liposuction for Arm Lymphedema Following Breast Cancer Surgery | ||
| NCT00005640 | Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer | ||
| NCT02652455 | Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma | ||
| NCT00815750 | Decision Making in Unaffected First-Degree Relatives of Prostate Cancer Patients | ||
| NCT03575325 | Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia | ||
| NCT05115474 | Study of Screening Brain MRIs in Stage IV Breast Cancer | ||
| NCT04760847 | Intermittent Fasting for Pancreatitis | ||
| NCT03451383 | Older Breast Cancer Patients: Risk for Cognitive Decline | ||
| NCT00216008 | Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation. | ||
| NCT04879940 | Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization | ||
| NCT02943642 | Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides | ||
| NCT06144606 | Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL) | ||
| NCT03628209 | Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma | ||
| NCT04319237 | Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes | ||
| NCT02945800 | Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma | ||
| NCT01606345 | Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma | ||
| NCT06144619 | Non-Invasive Biomarkers in Prostate Cancer Disease Management | ||
| NCT00104728 | Neoadjuvant IRESSA As Single Agent PreopTherapy for NSCLC With Molecular Correlates | ||
| NCT00005622 | Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders | ||
| NCT06423963 | Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer | ||
| NCT04343365 | Generating Novel Therapeutic Strategies Based on Evolutionary Tumor Board | ||
| NCT07194044 | Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes | ||
| NCT03026699 | Refining and Testing the Electronic Social Network Assessment Program (eSNAP) | ||
| NCT05170334 | Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma | ||
| NCT00499109 | Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC | ||
| NCT05526989 | Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma | ||
| NCT05751941 | Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer | ||
| NCT05921552 | Senior Adult Hepatobiliary Prehab Study | ||
| NCT00434109 | Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization | ||
| NCT00005793 | A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide | ||
| NCT01841021 | Pilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30 | ||
| NCT02186444 | Navigator Guided e-Psychoeducational Intervention | ||
| NCT05369546 | Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis | ||
| NCT01008527 | Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100 |
